SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Kesikburun, Ü. Güzelküçük, S. Alay, F. Yavuz, A. K. Tan, Exacerbation of myasthenia gravis by alendronate, Osteoporosis International, 2014, 25, 9, 2319

    CrossRef

  2. 2
    Douglas J DiGirolamo, Douglas P Kiel, Karyn A Esser, Bone and Skeletal Muscle: Neighbors With Close Ties, Journal of Bone and Mineral Research, 2013, 28, 7
  3. 3
    M. T. Kampman, E. F. Eriksen, T. Holmøy, Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?, Acta Neurologica Scandinavica, 2011, 124,
  4. 4
    M. Duyvendak, M. Naunton, E. N. Roon, G. A. W. Bruyn, J. R. B. J. Brouwers, Systematic review of trends in prophylaxis of corticosteroid-induced osteoporosis: the need for standard audit guidelines, Osteoporosis International, 2008, 19, 10, 1379

    CrossRef

  5. 5
    D.A. Lozsadi, G. Peters, H.Y. Sadik, M.W. Kellett, S.H. Fox, D.F. Smith, Prevention of osteoporosis in glucocorticoid-treated neurology patients, Clinical Neurology and Neurosurgery, 2006, 108, 2, 157

    CrossRef

  6. 6
    Nobuo Wakata, Hiroshi Nemoto, Hideki Sugimoto, Nobuatu Nomoto, Shingo Konno, Norihide Hayashi, You Araki, Atushi Nakazato, Bone density in myasthenia gravis patients receiving long-term prednisolone therapy, Clinical Neurology and Neurosurgery, 2004, 106, 2, 139

    CrossRef